Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO)
INR 15.2
(-4.94%)
INR 15.2
(-4.94%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 201.97 Million INR | -59.34% |
| 2022 | 496.69 Million INR | 164.73% |
| 2021 | 187.62 Million INR | -6.23% |
| 2020 | 200.08 Million INR | 10.34% |
| 2019 | 181.34 Million INR | 39.33% |
| 2018 | 130.14 Million INR | 43.12% |
| 2017 | 90.93 Million INR | 108.51% |
| 2016 | 43.61 Million INR | 35.96% |
| 2015 | 32.07 Million INR | -26.39% |
| 2014 | 43.57 Million INR | -1.38% |
| 2013 | 44.18 Million INR | -68.37% |
| 2012 | 139.7 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -576.39 Million INR | -100.0% |
| 2023 Q2 | 301.68 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 201.97 Million INR | -59.34% |
| 2023 Q4 | 201.97 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 496.69 Million INR | 0.0% |
| 2022 FY | 496.69 Million INR | 164.73% |
| 2022 Q2 | 146.71 Million INR | 0.0% |
| 2021 Q4 | 187.62 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 187.62 Million INR | -6.23% |
| 2021 Q2 | 197.68 Million INR | 0.0% |
| 2020 Q4 | 200.08 Million INR | 0.0% |
| 2020 FY | 200.08 Million INR | 10.34% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 201.58 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2019 FY | 181.34 Million INR | 39.33% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 181.34 Million INR | 0.0% |
| 2018 Q4 | 130.14 Million INR | 0.0% |
| 2018 Q2 | 84.96 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 130.14 Million INR | 43.12% |
| 2017 FY | 90.93 Million INR | 108.51% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q2 | 62.8 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q4 | 90.93 Million INR | 0.0% |
| 2016 Q1 | 28.38 Million INR | -11.51% |
| 2016 FY | 43.61 Million INR | 35.96% |
| 2016 Q4 | 43.61 Million INR | 51.58% |
| 2016 Q3 | 28.77 Million INR | -1.78% |
| 2016 Q2 | 29.29 Million INR | 3.2% |
| 2015 Q2 | 26.01 Million INR | -10.82% |
| 2015 FY | 32.07 Million INR | -26.39% |
| 2015 Q4 | 32.07 Million INR | 21.02% |
| 2015 Q3 | 26.5 Million INR | 1.9% |
| 2015 Q1 | 29.16 Million INR | -33.07% |
| 2014 Q4 | 43.57 Million INR | 10.33% |
| 2014 Q1 | 36.54 Million INR | -17.3% |
| 2014 FY | 43.57 Million INR | -1.38% |
| 2014 Q3 | 39.5 Million INR | -8.35% |
| 2014 Q2 | 43.1 Million INR | 17.94% |
| 2013 Q3 | 146.6 Million INR | 0.45% |
| 2013 Q4 | 44.18 Million INR | -69.86% |
| 2013 FY | 44.18 Million INR | -68.37% |
| 2013 Q2 | 145.95 Million INR | 0.79% |
| 2013 Q1 | 144.8 Million INR | 3.32% |
| 2012 Q4 | 140.15 Million INR | 0.0% |
| 2012 Q3 | - INR | -100.0% |
| 2012 Q2 | 142.12 Million INR | 0.0% |
| 2012 FY | 139.7 Million INR | 0.0% |
| 2011 Q4 | 144.84 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 25.7 Million INR | -685.858% |
| Sastasundar Ventures Limited | 1.5 Billion INR | 86.54% |
| KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | 79.729% |
| SHELTER PHARMA LIMITED | 20.99 Million INR | -862.239% |
| Vasundhara Rasayans Limited | 53.64 Million INR | -276.487% |
| Sunil Healthcare Limited | 902.83 Million INR | 77.629% |
| Chemo Pharma Laboratories Limited | 2.12 Million INR | -9391.259% |
| MedPlus Health Services Limited | 14.27 Billion INR | 98.585% |
| Zenith Healthcare Limited | 24.03 Million INR | -740.333% |
| Patidar Buildcon Limited | 25.57 Million INR | -689.825% |
| Sanjivani Paranteral Limited. | 155.06 Million INR | -30.251% |
| Roopa Industries Limited | 493.08 Million INR | 59.039% |
| Smruthi Organics Limited | 485.72 Million INR | 58.418% |
| Trident Lifeline Limited | 331.26 Million INR | 39.029% |
| Bacil Pharma Limited | 1.12 Million INR | -17789.637% |
| Pharmaids Pharmaceuticals Limited | 208.44 Million INR | 3.103% |
| Gujarat Terce Laboratories Limited | 161.67 Million INR | -24.927% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | 79.89% |
| Sandu Pharmaceuticals Limited | 118.22 Million INR | -70.842% |
| PANJON LTD. | 25.38 Million INR | -695.706% |
| Tyche Industries Limited | 101.64 Million INR | -98.713% |
| Trimurthi Limited | 101.36 Thousand INR | -199164.009% |
| TIAAN CONSUMER LIMITED | 14.97 Million INR | -1248.381% |
| Anuh Pharma Limited | 1.54 Billion INR | 86.924% |
| Crestchem Limited | 23.94 Million INR | -743.421% |
| Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -1406.706% |
| Zenlabs Ethica Limited | 301.35 Million INR | 32.978% |
| Vikram Thermo (India) Limited | 291.47 Million INR | 30.706% |
| ANG Lifesciences India Limited | 1.66 Billion INR | 87.845% |
| Parmax Pharma Limited | 117.56 Million INR | -71.794% |
| Fredun Pharmaceuticals Limited | 1.86 Billion INR | 89.149% |
| Deccan Health Care Limited | 111.33 Million INR | -81.409% |
| Norris Medicines Limited | 278.17 Million INR | 27.393% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | 88.218% |
| Veerhealth Care Limited | 62.78 Million INR | -221.717% |
| Makers Laboratories Limited | 569.18 Million INR | 64.515% |
| Lactose (India) Limited | 536.39 Million INR | 62.346% |
| OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | 75.758% |
| Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | 82.14% |
| Mercury Laboratories Limited | 171.18 Million INR | -17.983% |
| Gennex Laboratories Limited | 535.21 Million INR | 62.263% |
| PRAVEG LIMITED | 767.53 Million INR | 73.685% |
| Denis Chem Lab Limited | 289.82 Million INR | 30.311% |
| Kwality Pharmaceuticals Limited | 1.71 Billion INR | 88.232% |
| Jenburkt Pharmaceuticals Limited | 201.59 Million INR | -0.189% |
| Colinz Laboratories Limited | 24.1 Million INR | -737.893% |
| Godavari Drugs Limited | 957.86 Million INR | 78.914% |
| SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -67449.833% |
| Zenotech Laboratories Limited | 156.64 Million INR | -28.935% |
| Panchsheel Organics Limited | 340.2 Million INR | 40.631% |
| Shree Ganesh Remedies Limited | 488.36 Million INR | 58.643% |
| Vivanza Biosciences Limited | 148.63 Million INR | -35.89% |
| Phaarmasia Limited | 211.49 Million INR | 4.502% |
| Bharat Parenterals Limited | 2.65 Billion INR | 92.397% |
| Medi-Caps Limited | 63.01 Million INR | -220.512% |
| DECIPHER LABS LIMITED | 117.72 Million INR | -71.564% |
| Gujarat Themis Biosyn Limited | 197.37 Million INR | -2.331% |
| BDH Industries Limited | 312.53 Million INR | 35.376% |
| Vista Pharmaceuticals Limited | 175.16 Million INR | -15.304% |
| Coral Laboratories Limited | 281.83 Million INR | 28.337% |
| Concord Drugs Limited | 249.88 Million INR | 19.174% |
| Beryl Drugs Limited | 85.63 Million INR | -135.852% |
| Evoq Remedies Limited | 116.23 Million INR | -73.768% |
| Add-Shop E-Retail Limited | 159.2 Million INR | -26.865% |
| Transchem Limited | 6.72 Million INR | -2905.565% |
| Ishita Drugs and Industries Limited | 8.87 Million INR | -2176.533% |
| Parnax Lab Limited | 1.17 Billion INR | 82.748% |
| Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | -381.211% |
| Kerala Ayurveda Limited | 1.05 Billion INR | 80.903% |
| Cian Healthcare Limited | 1.03 Billion INR | 80.473% |
| Trinity League India Limited | 876 Thousand INR | -22956.393% |
| Syschem (India) Limited | 1.07 Billion INR | 81.137% |
| KOBO BIOTECH LIMITED | 2.04 Billion INR | 90.114% |
| Natural Capsules Limited | 1.47 Billion INR | 86.327% |
| Auro Laboratories Limited | 433.09 Million INR | 53.365% |